General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reconstruction meshes devices market, including market shares of different players within Taiwan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the reconstruction meshes market in Taiwan was Ethicon followed by Coloplast, W. L. Gore & Associates, Allergan Aesthetics, CR Bard, Integra LifeSciences, pfm medical, MTF Biologics, Boston Scientific, Surgalign and Baxter International.
The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however the meshes are separated based on the materials they are made from. Reconstruction Meshes include Synthetic Meshes, Biologic Meshes, Hybrid Meshes, and Slings. (*Note: Reconstruction Meshes specifically indicated for hernia repair were excluded, the data for which is presented in GlobalData’s Hernia Repair Devices.)
The value of the reconstruction meshes devices market within Taiwan was expected to be over $9m in 2023.
For the latest complete market share analysis of reconstruction meshes device market in Taiwan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
